Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

富山龙 - NMPA Drug Approval Details

Approvals/NMPA/Cefteram Pivoxil Tablets

Approved

化学药品

Cefteram Pivoxil Tablets

FUJIFILM TOYAMA CHEMICAL CO., LTD.🇨🇳 National Medical Products Administration

Approval Date: Nov 16, 2022
Approval ID: 6bad0c5f177290cf
Company: FUJIFILM TOYAMA CHEMICAL CO., LTD.
Type: 化学药品

Approval Details

Approval Id: 6bad0c5f177290cf
Approval Number: 国药准字HJ20150489
Generic Name: 头孢特仑新戊酯片
Generic Name En: Cefteram Pivoxil Tablets
Trade Name: 富山龙
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 0.1g
Reg Date: 2022-11-16
Expired Date: 2027-11-15
Company Name: FUJIFILM TOYAMA CHEMICAL CO., LTD.
Company Detail Path: /organization/fujifilm-toyama-chemical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 16, 2022

Approval ID

6bad0c5f177290cf

Type

化学药品

Back to NMPA Approvals